arrow
A

Ali Mojebi

merck & company
H指数:7
被引数:174

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials

更正:Aflibercept 8 mg 与 Faricimab Treat-and-Extend 治疗糖尿病黄斑水肿或新生血管性年龄相关性黄斑变性:一项基于临床试验的贝叶斯固定效应网络meta分析

2026-04-040
OAAI
Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials

Aflibercept 8 mg 与 Faricimab Treat-and-Extend 治疗糖尿病黄斑水肿或新生血管性年龄相关性黄斑变性:一项基于临床试验的贝叶斯固定效应网络Meta分析

2025-09-250
OAAI